US regulators say yes to SmartPill's diagnostic
This article was originally published in Clinica
Executive Summary
The FDA has given US company SmartPill the go-head to sell in the US its flagship product - an ingestible capsule for diagnosing and monitoring slow gastric emptying, or gastroparesis.